A study for a 34 year old woman who takes Levothyroxine Thyroid, Citalopram Hydrobromide - from FDA reports


Summary

528 females aged 34 (±5) who take the same drugs are studied. This is a personalized study for a 34 year old female patient who has Thyroid Cancer, Depression. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

528 females aged 34 (±5) who take Levothyroxine Thyroid, Citalopram Hydrobromide are studied.


Number of reports submitted per year:

Levothyroxine Thyroid, Citalopram Hydrobromide for a 34-year old woman.

Information of the patient in this study:

  • Age: 34
  • Gender: female
  • Conditions: Thyroid Cancer, Depression
  • Drugs taken:
    • Levothyroxine Thyroid (levothyroxine sodium)
    • Citalopram Hydrobromide (citalopram hydrobromide)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Vasculitis: 0 (0% of females aged 34 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • akathisia
  • chest pain
  • premature rupture of membranes
  • sleep disorder
  • pain in extremity
  • impetigo
  • conversion disorder
  • skin infection
  • dermatosis
  • flatulence
1 - 6 months:
  • thyroxine free increased
  • premature rupture of membranes
  • dizziness
  • hot flush
  • white blood cell count increased
  • sleep disorder
  • skin discoloration
  • heart palpitations
  • attention deficit hyperactivity disorder
  • vena cava injury
6 - 12 months:
  • premature rupture of membranes
  • pre-eclampsia
  • gestational diabetes
  • lymphocyte count decreased
  • granulocyte count increased
  • haemoglobin decreased
  • neutrophil count increased
  • blood thyroid stimulating hormone decreased
  • birth control
  • haematocrit decreased
1 - 2 years:
  • alopecia areata
2 - 5 years:
  • pain
  • injury
  • cholecystitis chronic
  • emotional distress
  • gallbladder injury
  • biliary dyskinesia
  • general physical health deterioration
  • cardiac failure congestive
  • high blood cholesterol
  • scar
5 - 10 years:
  • uterine perforation
  • pain
  • scar
  • device dislocation
  • panic disorder
  • procedural pain
  • device failure
  • libido increased
  • injury
  • medical device discomfort
10+ years:
n/a
not specified:
  • fatigue
  • nausea
  • pain
  • abdominal pain
  • pulmonary embolism
  • joint pain
  • fall
  • back pain
  • pain in extremity
  • weakness

Top conditions involved for these people *:

  • Birth Control (48 people, 9.09%)
  • Multiple Sclerosis (43 people, 8.14%)
  • Pain (33 people, 6.25%)
  • Crohn's Disease (29 people, 5.49%)
  • Nausea (22 people, 4.17%)

Top co-used drugs for these people *:

  • Yaz (43 people, 8.14%)
  • Yasmin (41 people, 7.77%)
  • Ambien (40 people, 7.58%)
  • Zyrtec (38 people, 7.20%)
  • Prednisone (34 people, 6.44%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Vasculitis (inflammation of a blood vessel or blood vessels) has been reported by people with rheumatoid arthritis, high blood pressure, osteoporosis, crohn's disease, multiple sclerosis (latest reports from 8,548 Vasculitis patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Vasculitis, Thyroid cancer, Levothyroxine thyroid, Depression, Citalopram hydrobromide

You may be interested in these reviews

More reviews for: Vasculitis, Thyroid cancer, Levothyroxine thyroid, Depression, Citalopram hydrobromide